AZ grabs EU approval for Imfinzi in advanced lung cancerThe European Commission has approved AstraZeneca’s immunotherapy drug Imfinzi (durvalumab) in a kind of lung cancer that was Share XAZ grabs EU approval for Imfinzi in advanced lung cancerhttps://pharmaphorum.com/news/az-grabs-eu-approval-for-imfinzi-in-advanced-lung-cancer/
